Barclays Upgrades GlaxoSmithKline (GSK) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
GlaxoSmithKline plc (GSK) Reports Q3 EPS of GBP0.08
October 22, 2014 7:04 AM EDTGlaxoSmithKline plc (NYSE: GSK) reported Q3 EPS of GBP0.08, versus GBP0.20 reported last year. Revenue for the quarter came in at GBP5.65 million, versus GBP6.51 million reported last year.
For earnings history and earnings-related data on GlaxoSmithKline plc (GSK) click here.
... More